Drugs linked to poor outcomes in older people with Alzheimer's disease

January 21, 2014

(Medical Xpress)—Exposure to high-risk drug classes is associated with higher rates of hospitalisation and mortality in older people with Alzheimer's disease, research by the University of Sydney has found.

The research paper, published in PLOS ONE journal, was authored by Dr Danijela Gnjidic, Lecturer and NHMRC Early Career Fellow from the Faculty of Pharmacy at University of Sydney.

Dr Gnijdic said that with and without Alzheimer's disease that are treated with high-risk classes, including a range of sedative and anticholinergic drugs, are more likely to be hospitalised and die than older people not treated with these drugs.

"The study revealed that increased cumulative exposure to anticholinergic and sedative drugs was associated with higher rates of hospitalisation and over one year in both people with and without Alzheimer's disease," Dr Gnjidic said.

"We found that 51% of people with Alzheimer's disease were exposed to drugs with anticholinergic and sedative effects, compared to 33% people without Alzheimer's disease."

Anticholinergic drugs are commonly used to treat asthma, incontinence, gastrointestinal cramps, and muscular spasms, and sedative drugs are prescribed for depression and sleep disorders.

"The study adds to the growing international body of evidence that the drug side-effects are a leading cause of preventable hospitalisation among older people," Dr Gnjidic said.

"Population-based research suggests that older people continue to take drugs with an unfavorable risk to benefit ratio.

"The study highlights the need for health practitioners and consumers to work together to implement evidence-based strategies to prevent and detect drug-related problems, particularly in older people with Alzheimer's disease," she said.

Explore further: Using anticholinergics for as few as 60 days causes memory problems in older adults

More information: Gnjidic D, Hilmer SN, Hartikainen S, Tolppanen A-M, Taipale H, et al. (2014) Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer's Disease: A National Population Cohort Study. PLoS ONE 9(1): e83224. DOI: 10.1371/journal.pone.0083224

Related Stories

Using anticholinergics for as few as 60 days causes memory problems in older adults

May 7, 2013
Research from the Regenstrief Institute, the Indiana University Center for Aging Research and Wishard-Eskenazi Health on medications commonly taken by older adults has found that drugs with strong anticholinergic effects ...

Anti-cholesterol drugs may do more harm than good for older people

June 3, 2013
The side effects of Australia's most commonly prescribed cholesterol-lowering drugs may outweigh the benefits in older people, a new clinical review has found.

Many Alzheimer's patients get drugs with opposing effects

October 25, 2011
You wouldn't brake your car while stepping on the gas—or wash down a sleeping pill with espresso. Yet many people taking common Alzheimer's disease medications—cholinesterase inhibitors—are given medications ...

People with Alzheimer's disease may have lower risk of cancer and vice versa

July 10, 2013
Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears ...

Commonly-prescribed drugs may influence the onset and progression of Alzheimer's disease

June 12, 2013
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings ...

FDA wants to relax approval process for Alzheimer's drugs

March 14, 2013
(HealthDay)—In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for the memory-robbing ...

Recommended for you

Lifestyle changes to stave off Alzheimer's? Hints, no proof

July 20, 2017
There are no proven ways to stave off Alzheimer's, but a new report raises the prospect that avoiding nine key risks starting in childhood just might delay or even prevent about a third of dementia cases around the world.

Blood test identifies key Alzheimer's marker

July 19, 2017
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that measures of amyloid beta in the blood have the potential to help identify people with altered levels of amyloid in their ...

Steering an enzyme's 'scissors' shows potential for stopping Alzheimer's disease

July 19, 2017
The old real estate adage about "location, location, location" might also apply to the biochemical genesis of Alzheimer's disease, according to new research from the University of British Columbia.

Brain scans may change care for some people with memory loss

July 19, 2017
Does it really take an expensive brain scan to diagnose Alzheimer's? Not everybody needs one but new research suggests that for a surprising number of patients whose memory problems are hard to pin down, PET scans may lead ...

Can poor sleep boost odds for Alzheimer's?

July 18, 2017
(HealthDay)— Breathing problems during sleep may signal an increased risk for Alzheimer's disease, a trio of studies suggests.

Hearing is believing: Speech may be a clue to mental decline

July 17, 2017
Your speech may, um, help reveal if you're uh ... developing thinking problems. More pauses, filler words and other verbal changes might be an early sign of mental decline, which can lead to Alzheimer's disease, a study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.